The effects of TTGM 5826 were not strictly correlated with tTG expression, perhaps because the relative amount of tTG in a crosslinking-active open state, rather than its total expression level, is the main factor determining the extent to which cancer cells are susceptible to this inhibitor. Here, TGM2 is linked to cancer.